ask="79.82"
ask_size="2000"
average_daily_volume="608362"
bid="72.00"
bid_size="900"
book_value="11.38"
change="+5.48"
change_from_200_day_moving_average="9.16"
change_from_50_day_moving_average="-0.15"
change_from_52_week_high="-27.30"
change_From_52_week_low="28.93"
change_in_percent="+7.83%"
close="75.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.66"
eps_estimate_next_year="-6.66"
ex_dividend_date="N/A"
float_shares="37661000"
high="76.21"
high_52_weeks="102.75"
last_trade_date="1/4/2017"
last_trade_price="75.45"
last_trade_size="61367"
last_trade_time="4:00pm"
low="70.31"
low_52_weeks="46.52"
market_capitalization="3.08B"
moving_average_200_day="66.29"
moving_average_50_day="75.60"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.67"
open="70.31"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+13.82%"
percent_change_from_50_day_moving_average="-0.20%"
percent_change_from_52_week_high="-26.57%"
percent_change_from_52_week_low="+62.19%"
previous_close="69.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.15"
price_per_sales="22335.19"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="465564"
weeks_range_52="46.52 - 102.75"
